Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit.
about
Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes databaseNovoPen Echo(®) insulin delivery deviceDiabetes care for emerging adults: recommendations for transition from pediatric to adult diabetes care systems: a position statement ...The role of comfort and discomfort in insulin therapyImproving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator.Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profileAdherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort studyClinical review: Diabetes in the adolescent: transitional issuesAdherence to therapies for secondary prevention of cardiovascular disease: a focus on aspirin.Adherence decision making in the everyday lives of emerging adults with type 1 diabetes.The prevalence of retinopathy in an unselected population of type 2 diabetes patients from Arhus County, Denmark.Achieving optimal diabetic control in adolescence: the continuing enigma.Hospital admission patterns subsequent to diagnosis of type 1 diabetes in children : a systematic reviewRecord-linkage for pharmacovigilance in ScotlandCorrelates of insulin injection omissionNutritional status, growth and disease management in children with single and dual diagnosis of type 1 diabetes mellitus and coeliac disease.Insulin as a substance of misuse in a patient with insulin dependent diabetes mellitus.Long-acting insulin analogs and the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes: a prospective study of 10,682 patients from 271 institutions.Autonomy or non-compliance in adolescent diabetes?Momentary assessment of social context and glucose monitoring adherence in adolescents with type 1 diabetesA Population Dose-Response Model for Inhaled Technosphere Insulin Administered to Healthy Subjects.Chronic conditions in adolescents.Executive functioning, treatment adherence, and glycemic control in children with type 1 diabetes.Diabetes management and glycemic control in youth with type 1 diabetes: test of a predictive model.Disinhibited eating and weight-related insulin mismanagement among individuals with type 1 diabetesDesign issues for drug epidemiology.Positive predictive value of automated database records for diabetic ketoacidosis (DKA) in children and youth exposed to antipsychotic drugs or control medications: a Tennessee Medicaid StudyEnhancing parental motivation to monitor african american adolescents' diabetes care: development and Beta test of a brief computer-delivered interventionHow to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus.Novopen Echo® for the delivery of insulin: a comparison of usability, functionality and preference among pediatric subjects, their parents, and health care professionalsAutomated bolus advisor control and usability study (ABACUS): does use of an insulin bolus advisor improve glycaemic control in patients failing multiple daily insulin injection (MDI) therapy? [NCT01460446].Psychological counselling in problematic diabetes: does it help?Transition of the adolescent from the children's to the adults' diabetes clinic.Implementing motivational interviewing in a pediatric hospital.The transition of adolescents with diabetes from the children's health care service into the adult health care service: a review of the literature.Considerations on blood glucose management in Type 2 diabetes mellitus.Adherence challenges in the management of type 1 diabetes in adolescents: prevention and intervention.Addressing dosing frequency in diabetes: a simple approach to improving adherence to therapy and clinical outcomes.Frequency and associated risk factors of recurrent diabetic ketoacidosis among Saudi adolescents with type 1 diabetes mellitusDesigning of peptides with desired half-life in intestine-like environment.
P2860
Q24654779-A30DB33B-7711-4FAE-BAAA-BA7F5D757A14Q26770486-CCD004AE-ECE5-414E-A011-846A9FEF67B4Q26865504-DA090AD6-633D-46F3-A17E-61031FC5E994Q27015671-1D979A54-A33C-4A19-8CBA-59D6BA6D1155Q27307805-EBB980A1-769E-42EF-9057-D4A0A5F89EEEQ27687563-BBA90762-D530-496E-9C04-420A5B7152F8Q28214017-E36FA5E8-3BEB-46D0-840C-EFAFDAD2AA66Q30219892-9E49056A-2042-4401-BF89-E368EECFB8C9Q30248710-8E4901A1-B93B-4400-B7F0-ACEB948FEFCFQ30542342-FF7A7D9D-81D5-455B-A1B5-936F8E80DC45Q31104469-F325E52D-08B3-430F-9ED0-FDCE8C2F1E36Q32164883-E4811486-A4AE-429D-9B8E-4CD1EF609222Q33308340-7DBEB717-934A-4BF9-ACCB-FF9AABEE8ABAQ33540453-0CC4BD4F-0EAE-4DBD-906C-598724E7258BQ33602102-3EFE6B5F-DCA4-4C5E-AE3C-43FD5651DE29Q33716251-BE5E1836-16F6-4727-91F4-2A9CC4AC265DQ33798964-383E61A0-3F0C-4378-8577-AB5F638E64D5Q33804600-20C78C09-E7EF-4384-BF0D-816A49DC8447Q33835355-16C1301D-FB85-4140-BB19-887A29C9037FQ33837878-FBC7EB1C-903D-46D4-B18D-1D196D843A3FQ33845504-27F056E7-B3C1-4CFF-B350-F3E288B8617BQ33847092-40F465D6-F355-4A6A-AB0A-E31A2CD97042Q33872989-CC762E1A-513C-46A3-A6B4-A7A91AABC458Q33880891-EFF54EC2-26C0-40C6-A688-51807CE78CE7Q34034192-BE3C94D0-D975-495B-B367-0C574B7A3558Q34078588-DE7F6BAE-DB28-458A-B9BA-686CA63D7AE8Q34082230-184E04B6-D573-4762-B95A-5724EFB08F03Q34268287-D4BCAA2B-403E-4ACB-BA77-0A2B48858D3CQ34344393-BBEFE7D2-5F0C-4728-83E5-D2D5C23211B4Q34420016-B279BFAD-9E1F-47BC-9E12-9047CB7C18D3Q34444545-BC4B057F-0BF7-4771-AD73-BB468A6F901FQ34593857-701E3E3F-8946-470B-8DC4-6087D316B9E9Q34636111-CC816503-682C-4AAD-87BD-8E33AFF3092BQ34667795-9FC45717-8669-4FEA-801C-D2FA5081CDF9Q34803028-9DC43692-1034-459D-94F2-942FC3F3CE15Q34804238-A8A3B4C0-C82A-4DAC-88A2-C3D2EC1EA805Q35174936-7EC74FC7-1A97-4F16-B883-EB6939C6A477Q35175088-94C8A559-FD28-4D5A-8D66-C5A72F34EE47Q35222078-D5357113-37D6-4B90-8995-BCB7217E7CDBQ35228840-5ADE5D87-7868-4254-992C-8BDBF375C1FD
P2860
Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit.
description
1997 nî lūn-bûn
@nan
1997 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Adherence to insulin treatment ...... nd. Medicines Monitoring Unit.
@ast
Adherence to insulin treatment ...... nd. Medicines Monitoring Unit.
@en
Adherence to insulin treatment ...... nd. Medicines Monitoring Unit.
@nl
type
label
Adherence to insulin treatment ...... nd. Medicines Monitoring Unit.
@ast
Adherence to insulin treatment ...... nd. Medicines Monitoring Unit.
@en
Adherence to insulin treatment ...... nd. Medicines Monitoring Unit.
@nl
prefLabel
Adherence to insulin treatment ...... nd. Medicines Monitoring Unit.
@ast
Adherence to insulin treatment ...... nd. Medicines Monitoring Unit.
@en
Adherence to insulin treatment ...... nd. Medicines Monitoring Unit.
@nl
P2093
P921
P1433
P1476
Adherence to insulin treatment ...... and. Medicines Monitoring Unit
@en
P2093
A D McMahon
A D Morris
R W Newton
S A Greene
P304
P356
10.1016/S0140-6736(97)06234-X
P407
P577
1997-11-01T00:00:00Z